Literature DB >> 11391044

Nonalcoholic fatty liver disease: implications for alcoholic liver disease pathogenesis.

A M Diehl1.   

Abstract

This article represents the proceedings of a symposium at the 2000 ISBRA Meeting in Yokohama, Japan. The presentation was Nonalcoholic fatty liver disease: Implications for alcoholic liver disease pathogenesis, by Anna Mae Diehl.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11391044     DOI： 10.1097/00000374-200105051-00004

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN： 0145-6008            Impact factor:   3.455


  16 in total

Review 1.  Multicausality in fatty liver disease: is there a rationale to distinguish between alcoholic and non-alcoholic origin?

Authors:  Henry Völzke
Journal:  World J Gastroenterol       Date:  2012-07-21       Impact factor: 5.742

2.  Indocyanine green clearance varies as a function of N-acetylcysteine treatment in a murine model of acetaminophen toxicity.

Authors:  Alessandra Milesi-Hallé; Susan M Abdel-Rahman; Aliza Brown; Sandra S McCullough; Lynda Letzig; Jack A Hinson; Laura P James
Journal:  Chem Biol Interact       Date:  2010-12-09       Impact factor: 5.192

3.  The latest idea in NAFLD/NASH pathogenesis.

Authors:  Masafumi Ono; Nobuto Okamoto; Toshiji Saibara
Journal:  Clin J Gastroenterol       Date:  2010-10-26

4.  Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice.

Authors:  Min You; Robert V Considine; Teresa C Leone; Daniel P Kelly; David W Crabb
Journal:  Hepatology       Date:  2005-09       Impact factor: 17.425

5.  Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study.

Authors:  Rohit Loomba; Hwai-I Yang; Jun Su; David Brenner; Elizabeth Barrett-Connor; Uchenna Iloeje; Chien-Jen Chen
Journal:  Am J Epidemiol       Date:  2013-01-24       Impact factor: 4.897

6.  The pathogenesis of ethanol versus methionine and choline deficient diet-induced liver injury.

Authors:  Maxwell Afari Gyamfi; Ivan Damjanov; Samuel French; Yu-Jui Yvonne Wan
Journal:  Biochem Pharmacol       Date:  2007-10-18       Impact factor: 5.858

7.  Biliary lipids and cholesterol crystal formation in leptin-deficient obese mice.

Authors:  Deborah A Swartz-Basile; Matthew I Goldblatt; Seong Ho Choi; Carol Svatek; Khoi Tran; Attila Nakeeb; Henry A Pitt
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

8.  Immunohistochemical characterization of hepatic malondialdehyde and 4-hydroxynonenal modified proteins during early stages of ethanol-induced liver injury.

Authors:  Brante P Sampey; Soheila Korourian; Martin J Ronis; Thomas M Badger; Dennis R Petersen
Journal:  Alcohol Clin Exp Res       Date:  2003-06       Impact factor: 3.455

9.  Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.

Authors:  Tania M Welzel; Barry I Graubard; Hashem B El-Serag; Yasser H Shaib; Ann W Hsing; Jessica A Davila; Katherine A McGlynn
Journal:  Clin Gastroenterol Hepatol       Date:  2007-08-06       Impact factor: 11.382

10.  Inhibition of Hsp72-mediated protein refolding by 4-hydroxy-2-nonenal.

Authors:  David L Carbone; Jonathan A Doorn; Zachary Kiebler; Brante P Sampey; Dennis R Petersen
Journal:  Chem Res Toxicol       Date:  2004-11       Impact factor: 3.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.